Pharmaceuticals, Biotechnology and Life Sciences
Food allergy has been essentially highly debatable for decades in atopicdermatitis, with some common food, including milk, egg, and soy. Thereis a lot of literature which provides evidence that common foodexacerbate atopic dermatitis.
TransPerfectLife Sciences, a leading provider of services and technologies tosupport global product development for the life sciences industry, hasreleased version 1.2 of myTI,the mobile application that enables real-time eTMF management andoversight for study teams on the go.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) todayannounced the launch of a generic version of Delzicol®1(mesalamine) delayed-release capsules, 400 mg, in the U.S.
Global oligonucleotide synthesis market is expected to reach $2.9billion by 2024, at a CAGR of 10.5% during the forecast period of 2019to 2024.
FDA) has granted Breakthrough Therapy Designation forSEP-363856, a novel agent for the treatment of people with schizophrenia.
The North America contract research organization (CRO) market isexpected to reach US$ 30,730.1 Mn in 2025 from US$ 16,369.3 Mn in 2017.
The global influenza vaccines market size is expected to surpass USD 6billion by 2025.
BioSpecifics reported net income of $4.4 million for the first quarter 2019, compared to net income of $4.0 million, for the same period in 2018.
Puma Biotechnology finished first quarter 2019 with Non-GAAP adjusted net income of $8.1M
Acceleron net loss for the first quartere 2019 $38.1M, R&D expenses $32.8